WASHINGTON, DC (IANS) – Drug makers Dr Reddy’s Laboratories, Sun Pharma and Aurobindo Pharma are recalling their products in the US due to manufacturing issues. According to the latest Enforcement ...

Sun Pharmaceutical ​Industries ‌on Saturday ​said ​it will acquire ⁠100% ​of ​Innovcare Lifesciences in ​a ​deal valued at ‌about ⁠2.71 billion rupees ($28.73 ​million).

The Nifty Pharma index gained 1.4% on Monday, 8 June, bucking the market selloff, as investors sought refuge in defensive sectors amid heightened global uncertainty, according to experts. The Nifty ...

Sun Pharmaceutical Industries’ $11.75-billion acquisition of Organon marks the largest deal in the company’s history and expands its presence in women’s health, specialty medicines and key ...

Sun Pharma notes that Doshi serves as an independent director on its board and does not hold any executive position within the company Sun Pharmaceutical Industries has disclosed the arrest of its ...

Sun Pharmaceutical Industries Ltd, the country's largest pharma company, on Thursday announced record and payment dates for the final dividend payment of Rs 5 per share for the financial year 2025-26 ...

State Bank of India (SBI) plans to join global lenders in funding Sun Pharmaceutical Industries’ $12 billion acquisition of US-listed Organon & Co. The government-run bank may commit up to $1 billion, ...

India's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash deal. This strategic move aims to bolster Sun Pharma's ...

Jefferies Financial missed second-quarter profit estimates on Wednesday as weakness in asset management overshadowed gains from robust dealmaking and ‌equity underwriting, sending its shares down 1.4% ...